ASMB News and Press, Assembly Biosciences Inc. From 11/08/23

Established partnership with Gilead Sciences to advance differentiated treatments for herpesviruses, HBV, HDV and beyond Now anticipate four development candidates from expanded pipeline in clinical development by the end of 2024 Named Anuj Gaggar, MD, PhD, as chief medical office...

2023-11-08 08:30:53 ET More on Assembly Biosciences Gilead and Assembly Bio ink deal for antiviral drugs Seeking Alpha’s Quant Rating on Assembly Biosciences Historical earnings data for Assembly Biosciences Financial information for Assembly Bioscienc...

-- Dr. Gaggar is an experienced industry executive with substantial infectious disease expertise and proven record of successfully leading early- and clinical-stage antiviral programs -- SOUTH SAN FRANCISCO, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), ...

2023-10-19 10:00:13 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Stocks to watch in the Health Care sector as earnings close in BofA reports 10th consecutive week of equity inflows For further...

2023-10-18 10:00:01 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Stocks to watch in the Health Care sector as earnings close in BofA reports 10th consecutive week of equity inflows For further...

2023-10-17 12:22:32 ET DENVER, Colo., Oct. 17, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Assembly Biosciences Inc (NASDAQ: ASMB), Nkarta Inc (NASDAQ: NKTX), Tempest Therapeutics Inc (NASDAQ: ...

2023-10-17 10:05:35 ET DENVER, Colo., Oct. 17, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Assembly Biosciences Inc (NASDAQ: ASMB), WiSA Technologies Inc (NASDAQ: WISA), SciSparc Ltd (NASDAQ: SPRC), A...

2023-10-17 07:58:47 ET More on Assembly Biosciences Seeking Alpha’s Quant Rating on Assembly Biosciences Historical earnings data for Assembly Biosciences Financial information for Assembly Biosciences For further details see: Gilead and Assembly B...

––Partnership combines Gilead’s proven track record and mission to develop transformative therapeutics targeting serious viral diseases, with Assembly Bio’s expertise and focus on antiviral R&D to advance differentiated treatments for herpesviruses, HBV, HDV and be...

-- One poster and one oral presentation selected, with the poster highlighting new preclinical data from the Company’s interferon- α receptor agonist program -- SOUTH SAN FRANCISCO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnol...